Uridine therapy for patients with elevated purine levels

Details for Australian Patent Application No. 2002211711 (hide)

Owner The Regents of the University of California Repligen Corporation

Inventors Moseley, Charles D.; Brewer, Deborah; Page, Theodore M.

Agent Davies Collison Cave

Pub. Number AU-B-2002211711

PCT Pub. Number WO02/30354

Priority 09689551 12.10.00 US

Filing date 12 October 2001

Wipo publication date 22 April 2002

Acceptance publication date 17 May 2007

International Classifications

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

A61K 31/7072 (2006.01)

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 21/02 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

C07H 19/067 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

17 May 2007 Application Accepted

  Published as AU-B-2002211711

13 September 2007 Standard Patent Sealed

6 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002211712

2002211710